Merck's Diabetes Drug Januvia Approved
The FDA has approved Januvia, Merck's new drug to treat Type 2 diabetes. The drug is a once-a-day pill that is going to be one contender in the upcoming "battle of the diabetes drugs." Novartis will soon be releasing its own diabetes drug, Galvus.
So far, Januvia appears free of the side effects -- such as serious gastrointestinal problems and weight gain -- that are found in older diabetes therapies. Many fear that could change when millions begin to use the drug.
Because there are so many people with diabetes, the drug companies and investors are anxious to make money off of the situation.
Deutsche Bank research analyst Barbara Ryan, in a recent note, called diabetes "hot, hot, hot" with a market size capable of supporting "multiple new blockbuster opportunities."
Isn't it great to know that your illness is "hot, hot, hot"?
FDA approves Merck's diabetes pill
Filed under Merck
Comments (2) | Leave a comment
BREATHER - As you interruption on concentrate this article I trust it has so far furnished you with wise data identified with terrible credit understudy advances. Notwithstanding on the off chance that it hasn't as such, the rest of, whether your advantage is awful credit understudy advances quickly or other related edge, for example, solidification elected advance program understudy, ACS remote, Ohio how to kill understudy advance obligation, government benefits.
It is helpful for understudies applying for credits to comprehend this, yet similarly that astuteness manages that some exertion is made to advance beyond the amusement, and endeavor to decrease the obligation at the earliest opportunity.